Anzeige
Mehr »
Login
Dienstag, 25.03.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Gold-Highflyer startet durch - Mega-Bohrprogramm sorgt für Kursfantasie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A414BN | ISIN: US47010C8881 | Ticker-Symbol: 1JA0
NASDAQ
24.03.25
19:42 Uhr
5,725 US-Dollar
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
JAGUAR HEALTH INC Chart 1 Jahr
5-Tage-Chart
JAGUAR HEALTH INC 5-Tage-Chart

Aktuelle News zur JAGUAR HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoXFRA 1JA0: AUSSETZUNG/SUSPENSION228DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILJAGUAR HEALTH 25...
► Artikel lesen
MoXFRA NEW INSTRUMENTS AVAILABLE ON XETRA 24.03.2025172The following instruments on XETRA do have their first trading 24.03.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 24.03.2025 Aktien 1 KYG93Y5D1039 VISEN Pharmaceuticals 2...
► Artikel lesen
FrXFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 21.03.2025434The following instruments on Boerse Frankfurt do have their last trading day on 21.03.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 21.03.2025.ISIN NameCA46500E1079 ISOENERGY...
► Artikel lesen
JAGUAR HEALTH Aktie jetzt für 0€ handeln
FrXFRA ISIN CHANGE311Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS47010C8055 Jaguar Health Inc. 21.03.2025 US47010C8881 Jaguar Health Inc. 24.03.2025 Tausch 25:1US45784G2003 Zoomcar...
► Artikel lesen
FrXFRA CAPITAL ADJUSTMENT INFORMATION - 21.03.2025202Das Instrument 2UH US00183L1026 ANGI INC DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 21.03.2025 und ex Kapitalmassnahme am 24.03.2025 The instrument 2UH US00183L1026 ANGI INC DL-,001 EQUITY...
► Artikel lesen
18.03.Why Jaguar Health (JAGX) Stock Is Trading Lower11
18.03.Jaguar Health falls as it announces reverse stock split15
18.03.Jaguar Health initiates reverse stock split to meet Nasdaq standards9
18.03.Jaguar Health leitet Aktienzusammenlegung ein, um NASDAQ-Standards zu erfüllen17
18.03.Jaguar Health, Inc. Announces Reverse Stock Split267Reverse split approved at March 2025 Special Meeting of StockholdersShares of Jaguar Health common stock to begin trading on split-adjusted basis on March 24, 2025 SAN FRANCISCO, CA / ACCESS Newswire...
► Artikel lesen
13.03.Jaguar Health, Inc. - 8-K, Current Report11
13.03.Jaguar Health, Inc.: Jaguar Health Reports Approval of All Proposals at March 2025 Special Meeting of Stockholders1.319Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion diseaseFDA...
► Artikel lesen
27.02.Jaguar Health, Inc.: Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value684Jaguar expects first results in Q2 2025 of proof-of-concept investigator-initiated trials of crofelemer for the rare diseases short bowel syndrome with intestinal failure and microvillus inclusion diseaseFDA...
► Artikel lesen
27.02.Jaguar Health, Inc. - 8-A12B, Registration of securities4
20.02.Jaguar Health, Inc. - 8-K, Current Report10
19.02.Jaguar Health, Inc.: Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure322This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications...
► Artikel lesen
18.02.Jaguar Health advances cholera treatment, eyes FDA voucher8
18.02.Jaguar Health, Inc.: Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300223Priority Review Vouchers (PRVs) are transferable and, in past transactions by other companies, have sold for prices up to $350 million1.3 to 4 million cholera cases and 21,000 to 143,000 cholera-related...
► Artikel lesen
13.02.Jaguar Health, Inc.: Jaguar Health Presenting February 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts382SAN FRANCISCO, CA / ACCESS Newswire / February 13, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Tuesday...
► Artikel lesen
06.02.Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference395Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as...
► Artikel lesen
Seite:  Weiter >>
100 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2